Hazard
2,383 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.
Of the 2,383 sterility recalls we have scored against our rubric, 1 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 2,113 (89%) are Severe.
Which agencies issued them
Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all sterility recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.
A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.
Pharmcore Inc. is recalling 1,115 vials of Methylcobalamin 10 mg due to a lack of assurance of sterility. The product was distributed nationwide.
Auro Pharmacies, Inc. is recalling 91 vials of Dexpanthenol injectable due to inadequate processes and equipment to assure sterility.
Auro Pharmacies is recalling 74 vials of Methyl-Cobalamin injectable because the manufacturer could not assure the sterility of the product.
Pharmcore Inc. is recalling 864 vials of Human Chorionic Gonadotropin 11000 IU due to a lack of assurance of sterility. The affected lots were distributed nationwide.
Auro Pharmacies is recalling 81 vials of Methyl-Cobalamin injectable because processes and equipment were inadequate to assure sterility.
Pharmcore Inc. is recalling 599 vials of Ipamorelin 9 mg because the company cannot assure the sterility of the product.
Pharmcore Inc. is recalling Ipamorelin 3 mg vials because the company cannot ensure the product is sterile.
Pharmcore Inc. is recalling 3,351 vials of Human Chorionic Gonadotropin 6000 IU due to a lack of assurance of sterility.
Auro Pharmacies, Inc. is recalling 40 vials of Folic Acid injectable due to inadequate processes and equipment to assure sterility.
Auro Pharmacies is recalling 39 vials of CoEnzyme-Q10 injectable because inadequate processes and equipment failed to assure product sterility.
Pharmcore Inc. is recalling 5,718 vials of Human Chorionic Gonadotropin 5000 IU due to a lack of assurance of sterility.
Ranier's Compounding Laboratory is recalling 60 vials of Morphine Sulf inhalation because practices at the firm may call into question the sterility of the product.
Ranier's Compounding Laboratory is recalling Dehydrated Alcohol Solution vials because practices at the firm may call into question the sterility of the products.
Ranier's Compounding Laboratory is recalling Acetylcysteine 10% Ophthalmic Solution due to a lack of assurance of sterility. The product was distributed in Pennsylvania.
Ranier's Compounding Laboratory is recalling Papav 300/Phent 5mg/10mL Injection due to lack of assurance of sterility. The product was distributed in Pennsylvania.
Ranier's Compounding Laboratory is recalling P/P/P Injection vials because practices at the firm may call into question the sterility of the product.
Ranier's Compounding Laboratory is recalling Medroxprogesterone 1% Ophthalmic Solution due to a lack of assurance of sterility. The product was distributed in Pennsylvania.
Ranier's Compounding Laboratory is recalling 213 Avastin prefilled syringes because practices at the firm may call into question the sterility of the products.
Ranier's Compounding Laboratory is recalling Triple P Injection due to practices that may call into question the sterility of the product.
Ranier's Compounding Laboratory is recalling Vitamin D3 Injection, 50,000 IU/mL, 4 mL vials, because practices at the firm may call into question the sterility of the product.
Ranier's Compounding Laboratory is recalling PRASH Injection vials because practices at the firm may call into question the sterility of the product.
Ranier's Compounding Laboratory is recalling P/P/P Injection vials because practices at the firm may call into question the sterility of the products.
Ranier's Compounding Laboratory is recalling PR/PA/PH Injection vials due to a lack of assurance of sterility. The product was distributed in Pennsylvania.
Ranier's Compounding Laboratory is recalling Pro/PA/PH/AT Injection in Pennsylvania due to a lack of assurance of sterility.
Guardian Pharmacy Services is recalling 1,000 vials of Magnesium Sulfate 200 mg/mL in Texas due to a lack of sterility assurance.